UK +44 (0)1865 849841
Malaysia +60 3 2117 5193
  • The Long Shadow Of The European Ruling On New Breeding Technologies

    Last week, the European Court of Justice ruled that gene-edited crops are equivalent to transgenic GMOs. 

  • Selecting A Formulation Type And Package Size For Your Biopesticides

    In the final instalment in our series of articles focusing on biopesticide product development, we will be discussing the importance of selecting a formulation type and package size, preferred packaging options, crop specific economics, tank mixability, and tank mixes.

  • Fermented Food As Probiotics: Health Perceptions And Research

    Fermented drinks can be, and often are, produced at home, although, as the numbers in this blog reveal, they also represent an important market in the food industry.

  • Engineering Complex Tissues: Let Nature Take Its Course

    Most tissues in our body are complex entities, containing multiple support structures like vascular networks. Ideally, this complexity should be reproduced when engineering a tissue substitute. This is important for functionality if the goal is to use the engineered tissue as a substitute for donor material, but also to ensure a physiological response in cases where the tissue will be used as a screening platform.

  • Novel Photosynthesis Technology – The Solution To The Global Food Security Crisis?

    The human population is increasing, which means that we need to improve crop productivity to maintain food security. 

Speaker profile: Jari Louhelainen

With many years experience in both cancer research and forensics, we spoke to Associate Professor of Biochemistry Jari Louhelainen about his career so far and what he thinks the future holds for molecular biology.

Read More

The key blockers to the adoption of digital pathology

In the first part of this six-part blog series, we looked at the challenges facing the pathology department. The conversation then moved onto the key blockers standing in the way of the adoption of digital pathology.

If you weren’t able to make the panel discussion, you can watch the recording here.

Read More

Developing Microbiome-Based Therapeutics & Novel Approaches to Metagenomic Research

As the understanding of the role that bacterial ecosystems play within human and animal health deepens, so has the increase in the amount of research and companies focusing on the Microbiome. If you were unable to attend the 6th Microbiome R&D and Business Collaboration Forum: USA, we have made these slides from Edward Burd, Kathy McCoy & Jan Majta available.

Read More

The future of Organ-On-A-Chip

Bas Trietsch is the CTO and co-founder of MIMETAS and co-inventor of the OrganoPlate. As CTO he currently drives the continued product development of the OrganoPlate and its peripheral equipment.

Here, Bas talks about what the future holds for organ-on-a-chip and other breakthroughs technologies in biology.

Read More

The challenges facing the pathology department

It was a pleasure to welcome key opinion leaders to a discussion on accelerating the impact of AI through 100% digitization of the pathology workflow. Chaired by Peter Hamilton, Head of Research at Philips Digital & Computational Pathology, barriers to adoption, what drives the need and how do we reap the benefits were all on the agenda.

If you weren’t able to make the panel discussion, this six-part blog series will uncover what was discussed. Alternatively, you can watch the recording here.

Read More

What is a Bioprocess Digital Twin?

Bioprocess digital twins are an exciting new technology that changes the way we do bioprocess development, process validation, and cGMP operations.

Read More

Skin Microbiome: Cosmeceutical Development, Sample Collection & Storage and Patient Stratification

Whilst microbiome as a whole is gaining traction, developments in wound healing, skin ageing and inflammation have garnered a wider understanding of the skin microbiome in health and disease. If you were unable to attend the dedicated Skin Microbiome track at the 6th Microbiome R&D and Business Collaboration Forum: USA, we have made these slides from Madhuri Jasti, Mark Wilson and Kausar Malik available here.

Read More

A microbiome solution for type 1 diabetes?

This article is republished with kind permission from Biovox. The original article can be found here.

Few things unite us the way trying to help a sick child does. Children living with the burden of type 1 diabetes (T1D) is just such a case. The desire to help young patients has galvanized a global effort, the TEDDY study, to understand what causes the disorder and pave the way for effective interventions. A number of analyses emerging from TEDDY are now bringing into focus the role of the microbiome in T1D. We now ask the question: could the microbiome be the key to intercepting and preventing T1D?

Read More

Speaker profile: Jari Louhelainen

With many years experience in both cancer research and forensics, we spoke to Associate Professor of Biochemistry Jari Louhelainen about his career so far and what he thinks the future holds for molecular biology.

Read More

The key blockers to the adoption of digital pathology

In the first part of this six-part blog series, we looked at the challenges facing the pathology department. The conversation then moved onto the key blockers standing in the way of the adoption of digital pathology.

If you weren’t able to make the panel discussion, you can watch the recording here.

Read More

Developing Microbiome-Based Therapeutics & Novel Approaches to Metagenomic Research

As the understanding of the role that bacterial ecosystems play within human and animal health deepens, so has the increase in the amount of research and companies focusing on the Microbiome. If you were unable to attend the 6th Microbiome R&D and Business Collaboration Forum: USA, we have made these slides from Edward Burd, Kathy McCoy & Jan Majta available.

Read More

The future of Organ-On-A-Chip

Bas Trietsch is the CTO and co-founder of MIMETAS and co-inventor of the OrganoPlate. As CTO he currently drives the continued product development of the OrganoPlate and its peripheral equipment.

Here, Bas talks about what the future holds for organ-on-a-chip and other breakthroughs technologies in biology.

Read More

The challenges facing the pathology department

It was a pleasure to welcome key opinion leaders to a discussion on accelerating the impact of AI through 100% digitization of the pathology workflow. Chaired by Peter Hamilton, Head of Research at Philips Digital & Computational Pathology, barriers to adoption, what drives the need and how do we reap the benefits were all on the agenda.

If you weren’t able to make the panel discussion, this six-part blog series will uncover what was discussed. Alternatively, you can watch the recording here.

Read More

What is a Bioprocess Digital Twin?

Bioprocess digital twins are an exciting new technology that changes the way we do bioprocess development, process validation, and cGMP operations.

Read More

Skin Microbiome: Cosmeceutical Development, Sample Collection & Storage and Patient Stratification

Whilst microbiome as a whole is gaining traction, developments in wound healing, skin ageing and inflammation have garnered a wider understanding of the skin microbiome in health and disease. If you were unable to attend the dedicated Skin Microbiome track at the 6th Microbiome R&D and Business Collaboration Forum: USA, we have made these slides from Madhuri Jasti, Mark Wilson and Kausar Malik available here.

Read More

A microbiome solution for type 1 diabetes?

This article is republished with kind permission from Biovox. The original article can be found here.

Few things unite us the way trying to help a sick child does. Children living with the burden of type 1 diabetes (T1D) is just such a case. The desire to help young patients has galvanized a global effort, the TEDDY study, to understand what causes the disorder and pave the way for effective interventions. A number of analyses emerging from TEDDY are now bringing into focus the role of the microbiome in T1D. We now ask the question: could the microbiome be the key to intercepting and preventing T1D?

Read More

The Top 5 Plant Genomics Articles of 2018

It has been an eventful year for plant genomics: we’ve seen advancements in plant disease research, the sequencing of the wheat genome, which was finally achieved through a worldwide collaboration of researchers spanning 13 years, and the ruling on the legal status of gene-edited crops. 

As 2018 draws to a close, we thought it was a good time to reflect. Here, we’ve collated our top articles of the year.

Read More

Microbiome within Plants, the Rhizophagy cycle and metagenomic discovery strategies

As a result of revolutionary breakthroughs in recent years, plant research has evolved dramatically. At the 6th Plant Genomics & Gene Editing Congress: USA, the latest NGS, “omic” and gene editing technologies being used for progressing plant based research were examined. If you weren’t able to be there in person, these slides are now available from Sharon Doty, James White & Axel Visel.

Read More

Can bacteriophages combat bacterial diseases of plants?

The bacterial nature of a plant disease was first proven in 1878–1880 by T. J. Burrill in the University of Illinois when studying fire blight. The number of known species of pathogenic bacteria is in constant change due to the clarification of phylogenetic relatedness upon receipt of new data, but as of 2014 the number of phytopathogenic bacteria genera that unite them was 39 1.

Read More

Case Study: High-throughput SNP Screening Downstream of CRISPR/Cas9 Gene Editing

One of the most powerful applications of genome editing is the introduction of nucleotide substitutions in specific genomic sites. This can be used to mimic single-nucleotide polymorphisms (SNPs) or to generate stop codons that yield precise gene knockouts. However, screening hundreds of clones for a single edited nucleotide remains a challenge, especially in the absence of a corresponding phenotype.

Read More

Challenges of epigenetic studies in plants: focus on ChIP technique

Agnieszka Zelisko-Schmidt from Diagenode elaborates on their poster presented at the 6th Plant Genomics & Gene Editing Congress: Europe, explaining how regulatory pathways in plants can be unravelled using the universal plant ChIP-seq kit.

Read More

Increasing Shelf Life of Perishable Produce Using Patented Gene Technology

The eIF‑5A protein is highly conserved in all plants and animals and is the only protein in any organism that has the unique hypusine modification caused by the Deoxyhypusine Synthase (DHS) enzyme. The unmodified-to-hypusinated ratio of these two forms of eIF‑5A determines the fate of the cell. Recent studies suggest that eIF‑5A is mainly involved in RNA metabolism and movement through the cell, thereby regulating cell growth, proliferation, and programmed death. These stable genetic changes will significantly enhance crop traits, including:

Read More

An Updated Round-Up of the Top Plant Genome Databases

There’s more plant genome databases than there ever has been before. We’ve collated the most recent databases for ontology information on a variety of crops, including: rice, maize, wheat, sorghum, barley, millet, rye, and oats.

Read More

EU Court of Justice Rules that Gene Edited Organisms will be Regulated as GMOs

On 25 July 2018, the Court of Justice of the European Union, the EU’s highest court, issued a decision clarifying whether the EU would regulate products of innovative breeding techniques, like gene editing, under the EU’s Directive 2001/18, the principal EU law governing the regulation of GMOs.

Read More

Examining Blockchain Systems & Designing Smart Contracts

The blockchain has the potential to enable the collaboration between patients, researchers, and care providers to provide individualised care for patients, but how can this technology be harnessed in a practical way?

This was one of the key questions that was asked at the Blockchain in Healthcare Congress and we had the pleasure of welcoming an array of expert speakers from pharma, academia, and industry to provide the answer.

Read More

The role of extrinsic motivation in sports and physical activity

Motivation is one of the most significant psychological concepts in many areas of life – from work and education to achieving personal goals. In sports and physical activity, motivation plays an especially important part due to the fact that, to millions of people worldwide, staying fit and active is not an obligation or a professional prerequisite, but rather a personal goal. Blockchain technology, together with elements of gamification, may actually help people achieve this goal.

Read More

Conciliating Blockchain and GDPR

Aurélie Bayle is a Data Protection Officer at be-ys: a role she considers to be at the heart of the new legal framework for any company.

Before GDPR came into effect on 25th May 2018, she was working towards global compliance, which involved completing all the steps given by the Article 29 Data Protection Working Party, an advisory board made up of a representative from the data authority of each EU Member State, the European Data Protection Supervisor, and the European Commission. Her duties have included auditing the structures and processes, preparing the data protection impact assessments, checking the compliance of processing activities, analysing the risks of the processing in the medical area, preparing new processes and policies about data protection, and asking data processors about their own compliance.

Read More

When Blockchain Meets the Right to be Forgotten: Technology Versus Law

Over the past few years, the popularity of the blockchain and cryptocurrencies has increased and has reached important notoriety, not only in scientific and IT journals, but also in the media. Although there are many kinds of cryptocurrencies in circulation nowadays, the most popular is Bitcoin.

Read More

Supporting Blockchain Startups: An Open Letter from Katherine Merton

Dear colleagues,

The blockchain technology market is expected to grow to 2.3 billion US dollars by 2021, from 339.5 million US dollars in 2017. [1] With an annual growth rate of 61.5%, it is one of the fastest growing technologies in the healthcare industry.

Read More

The Big List of Microfluidics Companies & Investors

The microfluidic-based devices market has been growing since 2014 due to the increasing point of care testing demand and the miniaturisation of microfluidic chips. 

Read More

What will we do with all this data?

The amount of data we are creating every day has increased exponentially to match the rise in use of smart and connected devices. The internet of things has connected every aspect of our lives to the digital realm: most of these devices operate by tracking your habits, movements, preferences, voice, and more, then logging those habits online. Specifically, the collection of health data has become abundant, because most people now have or wear some sort of device to track daily patterns, steps, cycles, and more. Even our phones often default to track these things for us, whether we choose to enable the function or not.

Read More

How Standards & Standardised Infrastructure Fuel Innovation

It might surprise a lot of people to learn that standards can be viewed as a tool to support innovation, to set businesses free and to focus on the core of their product where their expertise lie. When working with the use of electronic communication systems within the entire healthcare sector, the main focal point is often ensuring a good support for collaboration and work processes.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive